Katz, J <br/><br/>
Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw.  [electronic resource] 

 -  International journal of oral and maxillofacial surgery  Jun 2011 
 - 605-11 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1399-0020 
<br/><br/><label>Standard No.: </label>10.1016/j.ijom.2011.02.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Bone Density Conservation Agents--administration & dosage<br/>Cohort Studies<br/>Collagen Type I--genetics<br/>Collagen Type I, alpha 1 Chain<br/>Cytochrome P-450 CYP2C8<br/>Diphosphonates--administration & dosage<br/>Female<br/>Gene Frequency--genetics<br/>Humans<br/>Imidazoles--administration & dosage<br/>Injections, Intravenous<br/>Jaw Diseases--chemically induced<br/>Male<br/>Matrix Metalloproteinase 2--genetics<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Osteonecrosis--chemically induced<br/>Osteopontin--genetics<br/>Osteoprotegerin--genetics<br/>Pamidronate<br/>Polymorphism, Genetic--genetics<br/>Polymorphism, Single Nucleotide--genetics<br/>Receptor Activator of Nuclear Factor-kappa B--genetics<br/>Risk Factors<br/>Smoking<br/>Time Factors<br/>Tumor Necrosis Factor-alpha--genetics<br/>Zoledronic Acid